Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Sponsors › Genomics: Clinical Implementation › Biocartis Receives FDA Clearance for Viral Detection Panel

Biocartis Receives FDA Clearance for Viral Detection Panel

Sep 05, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Biocartis announced today that its Idylla Respiratory Panel (IFV-RSV) has been granted 510(k) clearance by the US Food and Drug Administration. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26
Featured Webinar

Responding to Emerging SARS-CoV-2 Variants: The Impact on Existing Diagnostic Testing and the Clinical Utility of Differentiation Assays

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.  

What's Popular?

In Infectious Disease

  1. SureScreen Dx Antigen Test Moves to Forefront of UK Effort to Control Spread of COVID-19

    Premium

  2. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

  3. Hamilton Storage, Harvard Spinout Rhinostics Partner for High-Throughput Sample Processing

  4. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  5. Finnish Diagnostic Firm Actim Gets CE Mark for SARS-CoV-2 Antibody Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.